CHICAGO – With its report Thursday that it lost $192.2 million in 2018 — 10 percent more than its $175.2 million net loss in 2017 — NantHealth continues to be a company in difficult financial waters.
Indeed, the Culver City, California-based molecular diagnostics and health IT arm of Patrick Soon-Shiong's NantWorks business empire remains on a Wall Street probation of sorts.
Get the full story with
360Dx Premium
Only $95 for the
first 90 days*
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try 360Dx Premium now.
You may already have institutional access!
Check if I qualify.
Already a 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
